Family Meeting Study for End Stage Renal Disease
Family Meeting Study for End Stage Renal Disease
A randomized clinical trial for patients with end stage renal disease in which a family
 consultation condition is compared against a treatment as usual control condition on the
 hospital readmissions after 1 month as the primary outcome variable.
Patients hospitalized at Henry For Hospital who have end stage renal disease will complete
 baseline questionnaires and be randomized into the experimental or control condition.
 Patients randomized into the experimental condition will have a single family consultation
 session before the patient is discharged. A trained, master's level therapist will conduct
 the family consultation, which will use education, motivational interviewing, and other
 techniques to help the family engage and support the patient's health needs. Patients in both
 the experimental and control conditions will complete follow up questionnaires 1 month after
 discharge. Investigators will conduct chart reviews of outcome data, including readmissions,
 at 1, 3, and 6 months post-discharge.
Inclusion Criteria:

 -  Hospitalized in inpatient Nephrology Unit at Henry Ford Hospital

 -  Has end-stage renal disease

 -  Willing and able to contact support person / family member about participating in the
 study

 Exclusion Criteria:

 -  Persistent Delirium

 -  Non-English speaking